NCT02469454View on ClinicalTrials.gov

Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions
ContraceptionNewbornChild DevelopmentGrowth
Interventions
DRUG

early insertion

Postpartum women into whom the etonogestrel-releasing contraceptive implant (Implanon®, N.V. Organon, Oss, Netherlands) will be inserted in the first 48 h postpartum.

DRUG

conventional insertion

Postpartum women into whom the etonogestrel-releasing contraceptive implant (Implanon®, N.V. Organon, Oss, Netherlands) will be inserted in the first 6 week of delivery.

Trial Locations (1)

14048900

Clinical Hospital of Sao Paulo University, Ribeirão Preto

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT02469454 - Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development | Biotech Hunter | Biotech Hunter